Akèy › Limfom Difize Gwo Selil B › Arkansas
Etid klinik pou Limfom Difize Gwo Selil B nan Arkansas
4 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan Arkansas.
Tèks ofisyèl etid la (Anglè)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Genesis Cancer and Blood Institute, Hot Springs
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06500273A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Genesis Cancer and Blood Institute ( Site 0193), Hot Springs
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06890884A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- University of Arkansas, Little Rock
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Highlands Oncology Group - Fayetteville, Fayetteville
- University of Arkansas for Medical Sciences, Little Rock
- Highlands Oncology Group - Rogers, Rogers
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT05633615Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.